SHELBY DAY: Open Payments
NPI 1982304374 · HIXSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 22 payments from 12 companies in 2025. Trend: 2023 $1,547 · 2024 $758 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $165 |
| ABBVIE INC. | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Lundbeck LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Boston Scientific Corporation | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, REXULTI, CAPLYTA, LEQVIO, Rybelsus, TRELEGY ELLIPTA, XIFAXAN.
Industry payments across TN — which companies pay providers there.
